• Following My Diagnosis, Negative Thoughts Consumed Me
  • Indalo Therapeutics Starts Phase 1 Trial Testing Antifibrotic Candidate IDL-2965
  • Despite Benefits, Many IPF Patients Switching from Esbriet to Ofev Stop Treatment, Possibly Due to Low BMI, Study Says
  • PFF Summit 2019 in Texas to Present the Latest Research Affecting the PF Community
  • Lessons I’ve Learned Since My IPF Diagnosis 3 Years Ago
  • Rare Gene Variants Linked to Worse Lung Transplant Outcomes in PF Patients
  • Finding Support While Going Through Difficult Times
  • IPF Patients Live Longer on Ofev Compared with Placebo, Analysis Suggests
  • Northwestern Doctor Awarded ATS Foundation/Boehringer Ingelheim Fellowship for IPF Research
  • 10 Exercise Myths and Truths: Advice from a Respiratory Specialist
  • Phase 1 Trial Testing PLN-74809 Supports its Clinical Development for IPF Treatment, Pliant Announces
  • The ‘Logan Boulet Effect’ and Its Impact on Patients with PF